Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients

Liver Transpl. 2015 Feb;21(2):272-4. doi: 10.1002/lt.24027.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepacivirus
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / surgery
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation
  • Male
  • Middle Aged
  • RNA, Viral / analysis
  • Recurrence
  • Ribavirin / therapeutic use*
  • Simeprevir
  • Sofosbuvir
  • Sulfonamides / therapeutic use*
  • Treatment Outcome
  • Uridine Monophosphate / analogs & derivatives*
  • Uridine Monophosphate / therapeutic use

Substances

  • Antiviral Agents
  • Heterocyclic Compounds, 3-Ring
  • Immunosuppressive Agents
  • RNA, Viral
  • Sulfonamides
  • Ribavirin
  • Simeprevir
  • Uridine Monophosphate
  • Sofosbuvir